Skip to main content
FDA OKs Subcutaneous Vedolizumab for Crohn’s Maintenance Therapy
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA OKs Subcutaneous Vedolizumab for Crohn’s Maintenance Therapy
User login
Username
Password
Reset your password
Concept
Lead
score
Crohn Disease
1
1
Geriatrics
0
0.61
Remission
0
0.61
Intravenous
0
0.26
Biologic Therapy
0
0.24
Ulcerative Colitis
0
0.24
Colitis
0
0.15
Edema
0
0.15
Food and Drug Administration (FDA)
0
0.15
Immunoglobulin A (IgA)
0
0.15
Monoclonal Antibody
0
0.15
Pain
0
0.15
Pruritus
0
0.15
Texas
0
0.15
Urticaria
0
0.15
Inflammatory Bowel Disease
0
0.12
Pain Management
0
0.12
Urticaria and Angioedema
0
0.12
Specialty
Lead
score
Gastroenterology
1
1
Internal Medicine
0
1
Hospital Medicine
0
0.48
Pharmacist
0
0.46
Family Medicine/Primary Care
0
0.29
Allergy & Clinical Immunology
0
0.24
Dermatology
0
0.12
Edit Tags